When about half of India's companies have price-to-earnings (or "P/E") ratios of less than 30 times, it can be considered Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) as…
Torrent Pharmaceuticals (NSE:TORNTPHARM) shares have risen 10.0% in the last three months. We wonder if and what role the company's financials play a role in…
The average one-year price target for TORRENT PHARMACEUTICALS (NSE:TORNTPHARM) has been revised to 2,111.00 / share. This is an increase of 10.81% from the prior…